Urgent

Rapid drug desensitisation

Inducing temporary tolerance to an essential culprit drug · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Rapid drug desensitisation delivers incrementally increasing doses of a culprit drug over hours to induce temporary tolerance when there is no acceptable alternative, as with chemotherapy, antibiotics or aspirin. It is a specialist, monitored procedure that does not cure allergy and must be repeated for each treatment course.

Red flags

  • History of SJS/TEN, DRESS or AGEP (absolute contraindication)
  • Haemodynamic instability during the protocol
  • Breakthrough anaphylaxis not controlled by pausing and treating
  • Organ-specific severe reactions (hepatitis, nephritis)
  • Lapse in dosing requiring restart

Assessment

Differential diagnosis

  • True IgE-mediated allergy (suitable for desensitisation)
  • Severe delayed T-cell reaction (SJS/TEN/DRESS — contraindication)
  • Non-immune intolerance / side effect
  • Infusion-rate reaction (may only need slower rate)
  • Anxiety or vasovagal reaction

Investigations

  • Confirm the reaction phenotype and exclude severe cutaneous adverse reactions
  • Skin testing / specific IgE to the culprit where available
  • Baseline and post-reaction mast cell tryptase
  • Confirm there is no safe alternative drug
  • Baseline observations and continuous monitoring during the protocol

Management

  • Exclude absolute contraindications (SJS/TEN, DRESS, severe organ-specific reactions)
  • Obtain informed consent and perform in a monitored setting with resuscitation facilities
  • Give premedication (antihistamine and corticosteroid) per protocol
  • Prepare serial dilutions and administer stepwise increasing doses at fixed intervals (e.g. 12-16 steps over 4-8 h)
  • Monitor continuously; for breakthrough reactions pause, treat, then resume at a lower step
  • Reach the full therapeutic dose and administer the treatment
  • Maintain continuous dosing thereafter — a lapse loses tolerance and the protocol must be repeated
  • Document the protocol and plan repeat desensitisation for each future course

Drugs & doses

Chlorphenamine — 10 mg IV/IM as premedication and for breakthrough reactions
Hydrocortisone — 100-200 mg IV as premedication
Adrenaline IM — 500 mcg (0.5 mL 1:1000) for breakthrough anaphylaxis
Montelukast — 10 mg orally as adjunct premedication in some protocols
Salbutamol — 5 mg nebulised for breakthrough bronchospasm

Disposition

Perform as an inpatient/day-case specialist procedure with monitoring; continue the drug uninterrupted and repeat desensitisation for each course.

Complications & pitfalls

  • Breakthrough anaphylaxis during escalation
  • Loss of tolerance if dosing is interrupted
  • Failure of desensitisation requiring alternative therapy
  • Delay to essential treatment
  • Procedure-related anxiety

Exam pearls

  • Desensitisation induces temporary tolerance only — it does not remove the allergy label permanently
  • Severe delayed reactions (SJS/TEN/DRESS) are absolute contraindications
  • Continuous, uninterrupted dosing is essential to maintain tolerance
  • Always perform in a monitored setting with immediate access to adrenaline

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.